4152.0 HIV, Hepatitis C, and Injecting Drug Use Across Diverse Populations and Settings

Tuesday, November 1, 2011: 12:30 PM

Board 3
Social Network Factors Associated with Hepatitis C Infection among Rural Appalachian Prescription Opioid Injectors
Jennifer Havens, PhD, MPH, Adam Jonas, MA, Carrie B. Oser, PhD and Carl Leukefeld, DSW
Board 4
Decreased Cognitive Performance in Illicit Drug Use in an Urban African-American Population
Pammie Gabrielle Renee Crawford, MPhil, SM, Xiaoqiang Xu, MS, Amy B. Wisniewski, PhD, Todd T. Brown, MD, PhD, Joseph Cofrancesco, MD, MPH, Ola Selnes, PhD and Adrian S. Dobs, MD, MHS
Board 5
Trends in injection drug use-related infective endocarditis in the United States, 1993-2007
Wendy Tseng, George Jay Unick, PhD, MSW, Daniel Rosenblum, PhD and Daniel Ciccarone, MD, MPH
Board 6
Discrimination, neighborhood factors and risky drug-using networks: Explaining the socio-contextual process of HIV transmission among illicit drug users in New York City (NYC)
Natalie Crawford, MPH, Carl Latkin, PhD, Sandro Galea, MD,DrPH, Chandra L. Ford, PhD, MPH, MLIS, Kandice Jones, MPH, Bruce G. Link, PhD and Crystal Fuller, PhD, MPH
Board 7
Social support and recovery efforts among Mexican female sex workers who inject drugs
Sarah Hiller, MPIA, Steffanie Strathdee, PhD, Maria Remedios Lozada, Dra, Angela Robertson, MPH, Jennifer Syvertsen, Thomas Patterson, PhD and Victoria D. Ojeda, PhD, MPH
Board 8
Integrating Rapid HIV Testing into Substance Abuse and Mental Health Treatment Settings: The Substance Abuse and Mental Health Services Administration Rapid HIV Testing Pilot
Warren Hewitt, MS, Kirk James, MD, Willie Tompkins, PhD, Naomi Tomoyasu, PhD, Resa F. Matthew, PhD, Kevin Hylton, PhD and Sherrye McManus, MSW, MSPH

See individual abstracts for presenting author's disclosure statement and author's information.

Organized by: Alcohol, Tobacco, and Other Drugs
Endorsed by: HIV/AIDS